2026-07-21 HIV_SYP(2)

Jul 21, 2026 07:37 · 30:04 · English · Whisper Turbo · 2 Ahotsak
Transkriptu hau iraungitzen da 8 egun. Biltegiratze iraunkorraren bertsio-berritzea →
Irakasgaiaren indizea
Erakutsi bakarrik
0:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's assuming no deficiencies.
0:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
That every single country went in and was approved immediately.
0:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
No questions from the Ministry of Health.
0:08
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We know that never happens.
0:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Even
0:21
S… Speaker 1 (2026-07-21 HIV_SYP(2))
with the most optimistic approach,
0:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we are off -market.
0:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Which
0:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
is the most significant country for this product?
0:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Which country is that second from the bottom?
0:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
India.
1:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Andrea,
1:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
do you want us to put an installation slide
1:07
S… Speaker 1 (2026-07-21 HIV_SYP(2))
for this one?
1:08
S… Speaker 1 (2026-07-21 HIV_SYP(2))
This needs to map.
1:18
S… Speaker 2 (2026-07-21 HIV_SYP(2))
study that um versus what's the commercial risk here from
1:22
S… Speaker 2 (2026-07-21 HIV_SYP(2))
us having the word high prevalence like like looking at the countries like if you scroll to the
1:26
S… Speaker 2 (2026-07-21 HIV_SYP(2))
left and the countries that are here like like a lot of the european countries would be kind of
1:30
S… Speaker 2 (2026-07-21 HIV_SYP(2))
these as high prevalence countries anyway regardless and maybe that's what the problem is but then
1:35
S… Speaker 2 (2026-07-21 HIV_SYP(2))
um in the emails that they were saying it was like you know around you
1:39
S… Speaker 2 (2026-07-21 HIV_SYP(2))
know like the likes of who and cdc and those guys trying to drive down HIV
1:43
S… Speaker 2 (2026-07-21 HIV_SYP(2))
and syphilis infection rates
1:45
S… Speaker 2 (2026-07-21 HIV_SYP(2))
So I was saying,
1:46
S… Speaker 2 (2026-07-21 HIV_SYP(2))
is it not the WHO product that would be used in that case,
1:50
S… Speaker 2 (2026-07-21 HIV_SYP(2))
not the AVDR product?
1:51
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And if that's the case,
1:53
S… Speaker 2 (2026-07-21 HIV_SYP(2))
we're not changing IP on the WHO product,
1:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
so we can still use it for those health matters.
1:57
S… Speaker 2 (2026-07-21 HIV_SYP(2))
But they didn't answer that question for me.
2:00
S… Speaker 2 (2026-07-21 HIV_SYP(2))
But if you scroll over to the left here,
2:02
S… Speaker 2 (2026-07-21 HIV_SYP(2))
so you can see the countries on the list.
2:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I'm
2:23
S… Speaker 2 (2026-07-21 HIV_SYP(2))
not sure about these countries,
2:24
S… Speaker 2 (2026-07-21 HIV_SYP(2))
which would be used for health rates.
2:31
S… Speaker 2 (2026-07-21 HIV_SYP(2))
infection matters like that in these countries like and i
2:41
S… Speaker 2 (2026-07-21 HIV_SYP(2))
guess i can see their issue like if you have that high prevalence in there then do we really have a market under these countries
2:46
S… Speaker 2 (2026-07-21 HIV_SYP(2))
because would they be factored as high prevalence areas elizabeth
2:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
would that notify the czech republic uh registration
2:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
with the ip check
3:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
3:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Andrea, I would also like to suggest,
3:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
while we're at it,
3:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we built,
3:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
if we got the alignment from marketing to go ahead,
3:45
S… Speaker 1 (2026-07-21 HIV_SYP(2))
what would that be?
3:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Let's say,
3:47
S… Speaker 1 (2026-07-21 HIV_SYP(2))
because we have to have to watch.
3:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Either we're going to do it or we're not going to do it.
3:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
How does that look like?
3:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
If we might as well just capture it in this moment,
3:56
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we have a backup plan.
3:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
If we
4:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
get alignment,
4:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
ASAP,
4:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We just need to do the notification and
4:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
translations and so forth.
4:40
S… Speaker 2 (2026-07-21 HIV_SYP(2))
If you move the next tab over
4:44
S… Speaker 2 (2026-07-21 HIV_SYP(2))
to your left,
4:45
S… Speaker 2 (2026-07-21 HIV_SYP(2))
46 .2 or 46 in
4:49
S… Speaker 2 (2026-07-21 HIV_SYP(2))
the brackets.
5:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay, okay.
5:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay, so is this one affected by the foil?
5:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yes.
5:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah,
5:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
5:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's in the list.
5:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah, I think,
5:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah. Yeah.
5:43
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we have the foil on this one.
5:45
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
5:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Can we see a little changes that come from this one
5:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
later? D5.
5:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
D5.
5:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Foil is there.
6:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Foil is there,
6:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah. I remember this one,
6:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
because the AFU,
6:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the formula change.
6:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
No, that's musical change.
6:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I remember I
6:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
saw the ABE.
6:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
This one
6:22
S… Speaker 1 (2026-07-21 HIV_SYP(2))
has
6:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the
7:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
gap in the R &R and I use
7:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
a lot in technical documents
7:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
perspective.
7:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The Chris ACL is big of things.
7:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Do we have a finalized iPhone this month with the States?
7:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
No,
7:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
it's marketing.
7:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
7:43
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Are we
7:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
ready
7:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to go and finalize iPhone?
7:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We're getting with it to
8:01
S… Speaker 1 (2026-07-21 HIV_SYP(2))
build out that.
8:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
plan for so if we assume that in the next week
8:07
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the conversation
8:33
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I see that marketing can be done.
8:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Dioro,
8:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4A1,
8:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
1B,
8:48
S… Speaker 1 (2026-07-21 HIV_SYP(2))
3B,
8:51
S… Speaker 1 (2026-07-21 HIV_SYP(2))
3B, 3B,
8:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
3B, 4B,
8:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B,
9:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B, 4B,
9:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B,
9:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B, 4B, 4B, 4B, 4B,
9:07
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B, 4B,
9:08
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4B, 4B,
9:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
4
9:22
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Just to give us an estimation
9:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
of what we need to complete.
9:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Payage
9:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
notification and then estimate the time.
10:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on the Wave 2 but it was on 4.
10:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's wave 2 and wave 2 to target notifications if it's July.
10:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We cannot make it.
10:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It needs to be wave 3 after the workshop and
10:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
alignment.
10:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And so if we are
10:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
discussing if it's LST or wave 2 or
10:43
S… Speaker 1 (2026-07-21 HIV_SYP(2))
wave 3, it's wave 2 right now.
10:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on hold.
10:47
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on wait.
10:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It was on hold.
10:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We can have a workshop where we can
10:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
discuss the wave street.
10:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
11:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
11:04
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Yeah.
11:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah.
11:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
There's nothing going on from white straight anyway too.
11:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
But my eyes are just for your
11:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
color.
11:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Because we do have stability
11:32
S… Speaker 1 (2026-07-21 HIV_SYP(2))
issues.
11:33
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Cluster.
11:36
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Stability.
11:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Cluster.
11:38
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
11:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The box.
11:42
S… Speaker 2 (2026-07-21 HIV_SYP(2))
The box.
11:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and your request to stop change to sign and there
11:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
was a discussion that we
11:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
have allowed each person to
11:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
change your request for change the box sign
12:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
after the workshop and online learning and
12:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
making a move and my discussion after the discussion of the seven
12:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
days
12:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So,
12:21
S… Speaker 2 (2026-07-21 HIV_SYP(2))
when we look at what was originally the way to do it,
12:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
syphilis
12:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I would say,
12:56
S… Speaker 2 (2026-07-21 HIV_SYP(2))
take it to be out of that.
12:57
S… Speaker 2 (2026-07-21 HIV_SYP(2))
The malaria age,
13:01
S… Speaker 2 (2026-07-21 HIV_SYP(2))
that's definitely needed.
13:03
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Syphilis,
13:06
S… Speaker 2 (2026-07-21 HIV_SYP(2))
right now,
13:07
S… Speaker 2 (2026-07-21 HIV_SYP(2))
we have the market alignment,
13:08
S… Speaker 2 (2026-07-21 HIV_SYP(2))
but you're still working on that.
13:10
S… Speaker 2 (2026-07-21 HIV_SYP(2))
So let's get to know that we get alignment with the market.
13:16
S… Speaker 2 (2026-07-21 HIV_SYP(2))
The A2 would be the next one,
13:19
S… Speaker 2 (2026-07-21 HIV_SYP(2))
that stays in the way that's really easy.
13:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So basically the two denariuses are higher.
13:22
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Yeah, yeah,
13:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
13:24
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And the I2,
13:26
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I2,
13:27
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I2, I2,
13:28
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I2, I2,
13:29
S… Speaker 2 (2026-07-21 HIV_SYP(2))
that's class B.
13:33
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we should be we should be okay but i
13:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
guess my question is
13:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
right if it comes to this which is
13:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Let's kind of close out on what we
13:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
need to do.
13:59
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And if we've got
14:05
S… Speaker 2 (2026-07-21 HIV_SYP(2))
marketing alignment,
14:06
S… Speaker 2 (2026-07-21 HIV_SYP(2))
the wrong way to get to do it.
14:13
S… Speaker 2 (2026-07-21 HIV_SYP(2))
With the design review,
14:15
S… Speaker 2 (2026-07-21 HIV_SYP(2))
what we need to see,
14:16
S… Speaker 2 (2026-07-21 HIV_SYP(2))
okay, how does that look?
14:18
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Getting to see notification.
14:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we have occasion
15:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah. Okay.
15:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Absolutely, but I guess that's my question. What should we want to do?
16:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So,
16:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
as long as we don't make any changes,
16:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
it's true.
16:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So do we have a close out in this line with you?
16:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we can see that.
16:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Oh,
16:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
OK.
16:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So that could be done.
16:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So what would it be with Labour,
16:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Labour and Labour?
16:48
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And you're saying it's women.
16:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
All of it,
16:53
S… Speaker 1 (2026-07-21 HIV_SYP(2))
don't you, because you,
16:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the PPS,
16:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
turns out that we do that.
17:30
S… Speaker 1 (2026-07-21 HIV_SYP(2))
prediction when when we say i think we just have our own
17:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
here to say if we're not doing the work
18:21
S… Speaker 1 (2026-07-21 HIV_SYP(2))
good thing is
18:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
19:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah, yeah, yeah.
20:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Thank you.
20:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So Andrea wasn't in to keep your radio and
20:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I was crazy.
20:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The two minutes were confirmed with
20:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the tea made upon the path that we had called the
20:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
CEO.
20:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
There was no more time going on in the document.
20:33
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So even though it shows out the review
20:37
S… Speaker 1 (2026-07-21 HIV_SYP(2))
in the case,
20:38
S… Speaker 1 (2026-07-21 HIV_SYP(2))
they still need to identify those documents in
20:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the entire time of the document.
20:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So two minutes looking at
20:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
what it would take to follow those documents to represent.
20:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Now in October,
20:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and then Grace's question
20:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
is,
21:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
she's driving to come back.
21:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So there is need for another product
21:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
in the queue.
21:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
But before we get back to that stage,
21:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we're going to look at why it's a cyclic dual.
21:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah?
21:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we're just building out.
21:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The really realistic plan was no changes
21:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to the items.
21:34
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay,
21:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so
21:57
S… Speaker 1 (2026-07-21 HIV_SYP(2))
capacity.
21:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Has that been considered for the other timelines
22:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
that we have lost?
22:11
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay. Okay.
22:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
22:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
All right.
22:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Let's look at this one.
22:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We get
22:24
S… Speaker 1 (2026-07-21 HIV_SYP(2))
documents updates.
22:26
S… Speaker 1 (2026-07-21 HIV_SYP(2))
The design review is going to be in October.
22:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
October.
22:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and then we have a month
23:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay,
23:17
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we're
23:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
saying...
23:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
um thank you
24:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and then and then we have red prep for six
24:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
months
24:13
S… Speaker 1 (2026-07-21 HIV_SYP(2))
For this one,
24:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we're not changing the
24:19
S… Speaker 1 (2026-07-21 HIV_SYP(2))
IP. IBD?
24:21
S… Speaker 1 (2026-07-21 HIV_SYP(2))
IBD.
24:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
We would need to send Elizabeth and then she needs four
24:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
months for the reason.
24:28
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yes.
24:29
S… Speaker 1 (2026-07-21 HIV_SYP(2))
When
24:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
could we start with registration here?
24:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Or which line
24:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I know is the spotline?
24:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Or which line I know is the name?
24:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Yeah,
24:56
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
25:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
okay so i think so i think for this one for this point you really say
25:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
best case scenario would just take us to the cutoff and
25:35
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to do a transition end of the year assuming
25:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Basically, the people will be able to deliver documents great.
25:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
It's closing down at the speed that we're delivering the documents for prioritization.
25:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And then the registration updates can start.
25:52
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So those countries will,
25:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
yeah.
25:55
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we'll just be able to get this day after this month based on the assessment
25:59
S… Speaker 1 (2026-07-21 HIV_SYP(2))
that's on record.
26:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So, do you want to detail a little bit with looking
26:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
at if this is just going to be a one?
26:12
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Do they all convert or do we need to get started?
26:16
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Okay,
26:20
S… Speaker 2 (2026-07-21 HIV_SYP(2))
perfect.
26:23
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Thank you.
26:25
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So that would be,
26:27
S… Speaker 1 (2026-07-21 HIV_SYP(2))
I think that's helping maybe raise to see or
26:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
to hear.
26:31
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So this would be where we could be due over now until
26:36
S… Speaker 1 (2026-07-21 HIV_SYP(2))
we understand clearly what's going to be the strength of the other product.
26:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
What it tells you,
26:40
S… Speaker 1 (2026-07-21 HIV_SYP(2))
then you look at the other products to see what is the best candidate
26:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
for you to pull into it.
26:47
S… Speaker 2 (2026-07-21 HIV_SYP(2))
I think the most.
26:51
S… Speaker 2 (2026-07-21 HIV_SYP(2))
efficient from my side is the hiv1 -2 because that was on the it's
26:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
not on the original wave one list that
27:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
would be the best
27:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So this one is in the copy,
27:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we put record to it.
27:20
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So we can switch now to HIV.
27:41
S… Speaker 1 (2026-07-21 HIV_SYP(2))
But I think what we don't go into the details
27:46
S… Speaker 2 (2026-07-21 HIV_SYP(2))
of HIV,
27:46
S… Speaker 1 (2026-07-21 HIV_SYP(2))
but what we just need to do is to maybe realign the priorities,
27:50
S… Speaker 1 (2026-07-21 HIV_SYP(2))
and we have one part of this.
27:51
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So there's just one list that everybody's looking at.
27:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
So I think that would be the priority on,
27:58
S… Speaker 2 (2026-07-21 HIV_SYP(2))
like, Thursday or Friday.
28:00
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Well, this one,
28:01
S… Speaker 1 (2026-07-21 HIV_SYP(2))
the system is dual,
28:03
S… Speaker 1 (2026-07-21 HIV_SYP(2))
as we just said now.
28:05
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Either way,
28:06
S… Speaker 1 (2026-07-21 HIV_SYP(2))
rent is not going to put energy into it now.
28:14
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we just we just need to go back to this if you couldn't see
28:18
S… Speaker 2 (2026-07-21 HIV_SYP(2))
me yeah yeah
28:35
S… Speaker 2 (2026-07-21 HIV_SYP(2))
And like,
28:36
S… Speaker 2 (2026-07-21 HIV_SYP(2))
oh, sorry,
28:37
S… Speaker 2 (2026-07-21 HIV_SYP(2))
are you changing all that?
28:38
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
28:39
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Okay.
28:39
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Because...
28:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So based upon this,
28:44
S… Speaker 1 (2026-07-21 HIV_SYP(2))
when we look at completion of work,
28:47
S… Speaker 1 (2026-07-21 HIV_SYP(2))
because we're looking at the blue box,
28:49
S… Speaker 1 (2026-07-21 HIV_SYP(2))
which would be then,
28:51
S… Speaker 1 (2026-07-21 HIV_SYP(2))
so we don't have ATV,
28:54
S… Speaker 1 (2026-07-21 HIV_SYP(2))
maybe we could just dull that one out a little bit.
28:58
S… Speaker 1 (2026-07-21 HIV_SYP(2))
And we're pushing the syphilis duo down for
29:02
S… Speaker 1 (2026-07-21 HIV_SYP(2))
a little bit.
29:04
S… Speaker 1 (2026-07-21 HIV_SYP(2))
So now we're going to confirm the AGPF
29:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
is in.
29:09
S… Speaker 1 (2026-07-21 HIV_SYP(2))
That's in.
29:10
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Then we
29:15
S… Speaker 1 (2026-07-21 HIV_SYP(2))
need to see,
29:16
S… Speaker 1 (2026-07-21 HIV_SYP(2))
do you go with PFPAN?
29:18
S… Speaker 1 (2026-07-21 HIV_SYP(2))
Have you done any work?
29:32
S… Speaker 2 (2026-07-21 HIV_SYP(2))
No, again,
29:32
S… Speaker 2 (2026-07-21 HIV_SYP(2))
we're probably not going to close out.
29:36
S… Speaker 2 (2026-07-21 HIV_SYP(2))
We can start
29:42
S… Speaker 1 (2026-07-21 HIV_SYP(2))
off.
29:42
S… Speaker 2 (2026-07-21 HIV_SYP(2))
But
29:51
S… Speaker 2 (2026-07-21 HIV_SYP(2))
would it not make more sense if HIV want to?
29:54
S… Speaker 2 (2026-07-21 HIV_SYP(2))
Again,
29:55
S… Speaker 2 (2026-07-21 HIV_SYP(2))
maybe we don't close out and I need to share with the team,
29:57
S… Speaker 2 (2026-07-21 HIV_SYP(2))
but if it's a class,
29:59
S… Speaker 2 (2026-07-21 HIV_SYP(2))
it will be sure it is a higher priority.

Transkriptu hau AI-k (hizketa-ezagutze automatikoak) sortu du. Erroreak izan ditzake - egiaztatu jatorrizko audioarekin, erabilpen kritikoa izan dadin. AI politika

❤️ Love STT.ai? Tell your friends!
Laburpena
Egin klik Laburpena botoian transkribapen honen AI laburpena sortzeko.
Laburpena...
Galdetu AI-ri transkribapen honi buruz
Egin ezazue galdera hau: transkribapen honi buruz, AI-ak atal egokiak aurkituko ditu eta erantzungo du.
Beste bat transkribatu